Regencell Bioscience Financials

Trends View

Profitability View

Liquidity View

Fundamentals View

Competition View

Regencell Bioscience Stock Summary

Regencell Bioscience competes with Phibro Animal, Sunshine Biopharma, Cosmos Health, Prestige Brand, and Collegium Pharmaceutical. Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine bioscience company. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong. Regencell Bioscience operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 13 people.

Regencell Bioscience Key Financial Ratios

Regencell Bioscience Key Balance Sheet Accounts

Regencell Bioscience Key Income Statement Accounts

Regencell Bioscience Key Cash Accounts

Regencell Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Regencell Bioscience's current stock value. Our valuation model uses many indicators to compare Regencell Bioscience value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Regencell Bioscience competition to find correlations between indicators driving Regencell Bioscience's intrinsic value. More Info.Regencell Bioscience Holdings is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Regencell Bioscience's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Regencell Bioscience's earnings, one of the primary drivers of an investment's value.

Regencell Bioscience Systematic Risk

Today, most investors in Regencell Bioscience Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Regencell Bioscience's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Regencell Bioscience growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Regencell Bioscience help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Regencell Bioscience Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of Regencell Bioscience Holdings based on widely used predictive technical indicators. In general, we focus on analyzing Regencell Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Regencell Bioscience's daily price indicators and compare them against related drivers.

When running Regencell Bioscience's price analysis, check to measure Regencell Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regencell Bioscience is operating at the current time. Most of Regencell Bioscience's value examination focuses on studying past and present price action to predict the probability of Regencell Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regencell Bioscience's price. Additionally, you may evaluate how the addition of Regencell Bioscience to your portfolios can decrease your overall portfolio volatility.